Sponsor Pipeline

PRG Science & Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05847179 Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner… Werner Syndrome Not Yet Recruiting
NCT06775041 Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics… Hutchinson-Gilford Progeria Syndrome Active, Not Recruiting
Phase 1/2
NCT07131722 Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients… Neurofibromatosis Type II Not Yet Recruiting
Phase 1
NCT07221240 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult… Amyotrophic Lateral Sclerosis Recruiting
Disease Areas
Get alerts when PRG Science & Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free